PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Macrophages express high level of Spp1, linking the environmental particle pollution exposure and the development of emphysema - an important finding for COPD

Macrophages express high level of Spp1, linking the environmental particle pollution exposure and the development of emphysema - an important finding for COPD
2025-02-20
(Press-News.org)

This study is led by Dr. Lianyong Han and Dr. Tobias Stoeger in Germany (Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, German Research Center for Environmental Health).

By analyzing multiple emphysema and COPD patient datasets, SPP1 is significantly upregulated in the lungs of patients, compared to healthy individuals. “These findings pointed out the clinical relevance of SPP1 induction during COPD development and has motivated us to understand their contributions in depth,” Dr. Han says.

In an experimental COPD model, Dr. Han has identified a sub-population of macrophages in the lung expressing high level of Spp1, and long-term cigarette smoking exposure caused persistent induction of Spp1 up to 6 months in these macrophages (Spp1+ macrophages). This finding is supported by advanced high-throughput single-cell RNA sequencing technique.

Similar to cigarette smoking, soot-like carbonaceous particles also caused long-term induction of Spp1, as well as the release of Osteopontin (OPN), a protein encoded by Spp1. “Consistently, OPN is also localized in macrophages in the lung, as revealed by our immunohistochemical staining,” Dr. Han says.

In a previous study from the same team, scientists found in a “second-hit model”, repeated carbonaceous particle exposure of gammaherpesvirus-infected mice caused lung emphysema. A further analysis by the team found a correlation between Spp1 induction and emphysema, subsequently highlighting the contribution of SPP1 to the development of air pollution-related COPD.

“Over 90% of the global population is still living in areas where air pollution levels exceed WHO guidelines of 10 μg/m3 for PM2.5, this is further aggravated by occupational exposure,” Dr. Stoeger says. Thus, the persistent particle challenges in the real-world pose long-term damage and injury to the lung, which finally contributes to the development of chronic lung diseases.

This study reveals a crucial mediator to environmental particle pollution-related chronic lung disease development and provides a potential preventive target.

 

See the article here:

Carbonaceous particle exposure triggered accumulation of Osteopontin/SPP1+ macrophages contributes to emphysema development

DOI: https://doi.org/10.1002/mco2.70061

END


[Attachments] See images for this press release:
Macrophages express high level of Spp1, linking the environmental particle pollution exposure and the development of emphysema - an important finding for COPD

ELSE PRESS RELEASES FROM THIS DATE:

Fitness apps fuelling disordered eating

Fitness apps fuelling disordered eating
2025-02-20
With New Year resolutions in full swing and health tracking apps at our fingertips, new research reveals concerning links between health and fitness apps and disordered eating, body image concerns and excessive exercise. “Diet and fitness apps are marketed as tools to improve health, however they may also have unintended negative consequences, such as creating pressure to meet goals, concerns about body image as well as provoking feelings of guilt if goals aren’t achieved,” says Ms Isabella Anderberg in the College of Education, Psychology and Social Work. “Whilst there is evidence that these tools can be effective in increasing physical activity, we’re ...

Duke-NUS study targets proteins to reverse lung scarring

2025-02-20
Singapore, 20 February 2025—A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in immune cells that, when blocked, could significantly reduce lung tissue scarring. Current treatments primarily manage symptoms and improving quality of life, without addressing the underlying cause of pulmonary fibrosis. Although macrophages, a type of immune cell, had previously been known to contribute to inflammation ...

New toolkit empowers healthcare providers with evidence-based strategies for childhood obesity prevention and treatment

New toolkit empowers healthcare providers with evidence-based strategies for childhood obesity prevention and treatment
2025-02-20
Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of Louisiana—is proud to announce the release of the Childhood Obesity Prevention, Evaluation and Treatment Toolkit, a comprehensive resource designed to equip healthcare providers with practical, evidence-based guidance for preventing, evaluating, and treating childhood obesity and its related comorbidities. Developed in alignment with the 2023 American Academy of Pediatrics (AAP) clinical practice guidelines, the toolkit synthesizes the latest scientific evidence and ...

UT MD Anderson and Texas Children’s Hospital announce joint venture to end childhood cancer

2025-02-20
HOUSTON ― The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated solely to pediatric cancer care. Approved by the UT System Board of Regents and the Texas Children’s Board of Trustees, this new, first-of-its-kind joint venture will unite the nation’s largest comprehensive pediatric system and a top pediatric cancer program with the nation’s leading comprehensive cancer center. The collaboration has a single ...

Texas Children’s Hospital and UT MD Anderson announce joint venture to end childhood cancer

2025-02-20
HOUSTON, TX (February 19, 2025) – Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center have announced a transformational collaboration dedicated solely to pediatric cancer care. Approved by the Texas Children’s Board of Trustees and the UT System Board of Regents, this new, first-of-its-kind joint venture will unite the nation’s largest comprehensive pediatric system and a top pediatric cancer program with the nation’s leading comprehensive cancer center. The collaboration has a single mission: to end childhood cancer. “The scope and scale of our combined effort will build the world’s preeminent pediatric cancer ...

New medication sinus thrombosis just as safe but more patient-friendly

2025-02-20
Patients affected by sinus thrombosis are treated with blood thinners. Traditionally, these patients are prescribed vitamin K antagonists (VKAs). In order to give the correct dosage, regular check-ups at the thrombosis service are necessary. A global study, coordinated by Amsterdam UMC, now shows that new medication, direct oral anticoagulants (DOACs), are equally safe and effective. The study was published today in The Lancet Neurology.  A big advantage is that this medication is more user-friendly because regular thrombosis monitoring is no longer ...

About 740,000 global deaths from suicide occur annually--that's one death every 43 seconds

2025-02-20
Every minute, four males and six females need inpatient treatment due to suicide attempts around the world. Males die from suicide at twice the rate of females, and their attempts result in death three times more often than female attempts. Globally, 10% of suicides by males and 3% by females were with guns. In the U.S., 55% by males and 31% by females were with guns. Between 1990 and 2021, the global age-standardized death rate for suicide declined by almost 40%, indicating that intervention and prevention are ...

Experts strongly recommend against spine injections for chronic back pain

2025-02-20
Spine injections should not be given to adults with chronic back pain because they provide little or no pain relief compared with sham injections, say a panel of international experts in The BMJ today. Their strong recommendations apply to procedures such as epidural steroid injections and nerve blocks for people living with chronic back pain (lasting at least 3 months) that is not associated with cancer, infection or inflammatory arthritis. Their advice is based on the latest evidence and is part of The BMJ’s ‘Rapid ...

Racism in medicine - are things getting better?

2025-02-20
Five years on since The BMJ’s special issue on racism in medicine, and a global pandemic, the landscape is very different, but has racism in the NHS and UK medicine got better or worse? In 2020, a BMJ investigation found that UK medical schools were failing to deal with complaints of racism. Another round of requests to the UK’s 46 medical schools has now found that eight in 10 (34 of 41 that responded) are collecting data on complaints about racism, up from half in 2020. And the number ...

Forcing UK creatives to ‘opt out’ of AI training risks stifling new talent

2025-02-20
The UK government should resist allowing AI companies to scrape all copyrighted works unless the holder has actively “opted out”, as it puts an unfair burden on up-and-coming creative talents who lack the skills and resources to meet legal requirements. This is according to a new report from University of Cambridge experts in economics, policy and machine learning, who also argue the UK government should clearly state that only a human author can hold copyright – even when AI has been heavily involved. A collaboration between three Cambridge initiatives – ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Macrophages express high level of Spp1, linking the environmental particle pollution exposure and the development of emphysema - an important finding for COPD